Sorafenib shows promise in the treatment of people with acute myeloid leukemia who have gene mutations, say University of Texas M.D. Anderson Cancer Center researchers. (Jan. 29. Journal of the National Cancer Institute)
Sorafenib shows promise in the treatment of people with acute myeloid leukemia who have gene mutations, say University of Texas M.D. Anderson Cancer Center researchers. (Jan. 29. Journal of the National Cancer Institute)
